June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Giannis Mountzios: ELCC25 MARIPOSA trial – Overall Survival in 1L EGFR-mutant NSCLC
Mar 26, 2025, 19:20

Giannis Mountzios: ELCC25 MARIPOSA trial – Overall Survival in 1L EGFR-mutant NSCLC

Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared on X:

“ELCC25 MARIPOSA trial OS in 1L EGFR-mutant NSCLC:
Ami+Laze vs Osi:

  • mOS NR vs 36.7 m
  • HR 0.79 for CNS progression
  • median ic DoR 35.7 months
  • projected OS benef> 12 months
  • prophylactic anticoagulant and Steroid for iRR

Game changer in 1L. Patients with co-mutations?”